FDA Inspection 734444 — McLaughlin, Vallerie, MD

McLaughlin, Vallerie, MD — FEI 3007094463

The FDA completed an inspection of McLaughlin, Vallerie, MD on May 19, 2011 in Ann Arbor, MI. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
May 19, 2011
Fiscal Year
2011
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Ann Arbor, MI (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
755221 CFR 312.66Changes in research
756021 CFR 312.60FD-1572, protocol compliance